Dr. Gregory Kent Bergey, MD

Dr. Bergey practices at The Johns Hopkins Hospital in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Bergey's NPI, 1740246123, was assigned on April 25, 2006. Dr. Bergey graduated from Perelman School of Medicine - Philadelphia in 1975. Dr. Bergey holds Maryland license D25994.

Dr. Bergey's primary practice is The Johns Hopkins Hospital, at 600 North Wolfe Street, Baltimore, MD 21287 in Baltimore City. The practice phone is (410) 955-9540.

Dr. Bergey's primary practice is The Johns Hopkins Hospital in Baltimore, Maryland, part of Johns Hopkins Health System. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Bergey to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bergey practices. Vendor and product names are available with a free account.

Neurology is Dr. Bergey's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bergey is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bergey's licenses on file in 4 states: Maryland, Florida, North Carolina and Alabama.

Dmand AI lists epilepsy, headaches, migraine and chronic headache and seizures among the conditions Dr. Bergey treats.

CMS data shows 96 Medicare services from Dr. Bergey across 2 procedure codes in 2024, for 84 Medicare patients. Medicare paid $9,248 for them.

CMS counts 84 Medicare patients who saw Dr. Bergey in 2024. The largest group is under 65, with 40 patients. 62% of them have high cholesterol, and 60% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bergey's median patient age at 59, with 67% women.

In 2024, Dr. Bergey wrote 1,016 Medicare Part D claims for 120 patients. 80% of them were for generic drugs. CMS names the drug for 877 of them, across 21 drugs with 11 or more claims each, at $301,278 in total drug cost. In 2023, CMS named 1,021 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Bergey for performance year 2024, reported as part of a group.

Dmand AI links 85 papers to Dr. Bergey, published from 2003 to 2023. 2014 was the busiest year, with 7. The most frequent topics are Electroencephalography, Epilepsy and Cells, Cultured. Dr. Bergey has published most often in Clin Neurophysiol. Dr. Bergey's most frequent co-authors are William Stanley Anderson, MD, Nathan Earl Crone, MD and Aizik L. Wolf, MD.

CMS Open Payments shows 18 general payments to Dr. Bergey from 7 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 37% of the total. Neuropace, Inc. paid the most, $4,053. It also lists 7 research payments totaling $57,303 from 2016 to 2017.

Dmand AI lists 5 awards for Dr. Bergey, most recently America's Top Doctors in 2014.

Dr. Bergey graduated from Perelman School of Medicine - Philadelphia in 1975. Dr. Bergey is a member of AAN.

Dr. Bergey is in network with 4 carriers, including Blue Cross Blue Shield of Michigan, Elevance and CareFirst BlueCross BlueShield. PPO plans come from the most carriers, 3. Check the plan with the practice before a visit.